Battelle

Battelle operates as a non-profit research and development organization funded primarily through government contracts, particularly from DARPA. They develop the NeuroLife brain-computer interface system, which uses an implanted cortical recording array and a muscle stimulation sleeve to restore hand and arm movement in patients with spinal cord injuries. Revenue is recognized as contract milestones are met on multi-year government research programs. The core economic structure is cost-plus or fixed-price government R&D contracting, where Battelle recovers direct research costs plus an agreed-upon fee. What scales is the organization's ability to win follow-on and new contract vehicles as their technology demonstrates clinical results. The clinical trial infrastructure and regulatory pathway work are subsidized by government funding, not commercial revenue. As a non-profit, Battelle reinvests any operating surplus into further research rather than distributing it to shareholders. There is no product revenue stream yet — the organization's sustainability depends entirely on continued government interest in neural interface research and successful contract renewals.